
Keywords: BPA, Bisphenol A; SF-1, steroidogenic factor-1; ACTH, Adrenocorticotropic hormone; StAR, steroidogenic acute regulatory protein; CYP, cytochrome P450; 3β-HSD, 3β-hydroxysteroid dehydrogenase; NOAEL, no observed adverse effect level; 17β-HSD, 17β-hydroxyst